Nutriband Stock Performance
| NTRB Stock | USD 7.21 0.19 2.57% |
Nutriband holds a performance score of 9 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 1.27, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nutriband will likely underperform. Use Nutriband expected short fall, and the relationship between the value at risk and daily balance of power , to analyze future returns on Nutriband.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Nutriband are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nutriband sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 7.33 | Five Day Return (1.00) | Year To Date Return 62.53 | Ten Year Return 28.83 | All Time Return 28.83 |
Last Split Factor 1166:1000 | Dividend Date 2019-07-24 | Last Split Date 2022-08-12 |
1 | Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa Abuse Deterrent Transdermal Technology | 11/27/2024 |
2 | Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94 percent YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 | 12/04/2024 |
3 | Nutriband Extends Chinese Patent to Macao for its AVERSA Abuse Deterrent Transdermal Technology | 12/27/2024 |
4 | Investors ignore increasing losses at Nutriband as stock jumps 19 percent this past week | 01/02/2025 |
5 | Nutriband Now Covered by Analysts at Noble Financial | 01/23/2025 |
6 | NutriBand Shareholders Approve Key Proposals at Annual Meeting - Investing.com | 01/29/2025 |
7 | Why Nutriband Inc Is Skyrocketing So Far In 2025 | 02/04/2025 |
8 | Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa Fentanyl Abuse Deterrent Fentanyl Patch | 02/13/2025 |
9 | Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and ... | 02/21/2025 |
| Begin Period Cash Flow | 2 M |
Nutriband |
Nutriband Relative Risk vs. Return Landscape
If you would invest 480.00 in Nutriband on November 29, 2024 and sell it today you would earn a total of 253.00 from holding Nutriband or generate 52.71% return on investment over 90 days. Nutriband is currently generating 1.1699% in daily expected returns and assumes 10.2187% risk (volatility on return distribution) over the 90 days horizon. In different words, 91% of stocks are less volatile than Nutriband, and 77% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nutriband Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nutriband's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nutriband, and traders can use it to determine the average amount a Nutriband's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1145
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NTRB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.22 actual daily | 91 91% of assets are less volatile |
Expected Return
| 1.17 actual daily | 23 77% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 9 91% of assets perform better |
Based on monthly moving average Nutriband is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nutriband by adding it to a well-diversified portfolio.
Nutriband Fundamentals Growth
Nutriband Stock prices reflect investors' perceptions of the future prospects and financial health of Nutriband, and Nutriband fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nutriband Stock performance.
| Return On Equity | -0.6 | ||||
| Return On Asset | -0.3 | ||||
| Operating Margin | (4.62) % | ||||
| Current Valuation | 76.63 M | ||||
| Shares Outstanding | 11.11 M | ||||
| Price To Earning | (15.98) X | ||||
| Price To Book | 7.31 X | ||||
| Price To Sales | 40.62 X | ||||
| Revenue | 2.09 M | ||||
| Gross Profit | 804.61 K | ||||
| EBITDA | (5.12 M) | ||||
| Net Income | (5.49 M) | ||||
| Cash And Equivalents | 3.34 M | ||||
| Cash Per Share | 0.43 X | ||||
| Total Debt | 241.28 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 5.12 X | ||||
| Book Value Per Share | 0.73 X | ||||
| Cash Flow From Operations | (3.53 M) | ||||
| Earnings Per Share | (0.71) X | ||||
| Market Capitalization | 109.95 M | ||||
| Total Asset | 7.52 M | ||||
| Retained Earnings | (27.98 M) | ||||
| Working Capital | 22.77 K | ||||
| Current Asset | 33.76 K | ||||
| Current Liabilities | 13.08 K | ||||
About Nutriband Performance
By analyzing Nutriband's fundamental ratios, stakeholders can gain valuable insights into Nutriband's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nutriband has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nutriband has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 45.28 | 31.80 | |
| Return On Tangible Assets | (2.70) | (2.84) | |
| Return On Capital Employed | (0.67) | (0.71) | |
| Return On Assets | (0.66) | (0.69) | |
| Return On Equity | (0.77) | (0.81) |
Things to note about Nutriband performance evaluation
Checking the ongoing alerts about Nutriband for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nutriband help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nutriband is way too risky over 90 days horizon | |
| Nutriband appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 2.09 M. Net Loss for the year was (5.49 M) with profit before overhead, payroll, taxes, and interest of 804.61 K. | |
| Nutriband currently holds about 3.34 M in cash with (3.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.43. | |
| Roughly 54.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and ... |
- Analyzing Nutriband's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nutriband's stock is overvalued or undervalued compared to its peers.
- Examining Nutriband's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nutriband's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nutriband's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nutriband's stock. These opinions can provide insight into Nutriband's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Nutriband Stock analysis
When running Nutriband's price analysis, check to measure Nutriband's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutriband is operating at the current time. Most of Nutriband's value examination focuses on studying past and present price action to predict the probability of Nutriband's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutriband's price. Additionally, you may evaluate how the addition of Nutriband to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |